Technical Analysis for VLRXQ - Valeritas Holdings Inc

Grade Last Price % Change Price Change
grade C 0.031 3.33% 0.0010
VLRXQ closed up 3.33 percent on Tuesday, April 7, 2020, on 59 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical VLRXQ trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Boomer Sell Setup Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 3.33%
1,2,3 Retracement Bearish Bearish Swing Setup 3.33%
Older signals for VLRXQ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey. On February 9, 2020, Valeritas Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Medicine RTT Clinical Medicine Diabetes U.S. Bankruptcy Court Medical Technology U.S. Bankruptcy Court For The District Of Delaware Endocrine System Peptide Hormones Eli Lilly And Company Insulin Recombinant Proteins Insulin Delivery Type 1 Diabetes

Is VLRXQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.139
52 Week Low 0.016
Average Volume 72,559
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0334
10-Day Moving Average 0.0363
Average True Range 0.0288
ADX 37.43
+DI 9.3138
-DI 10.9983
Chandelier Exit (Long, 3 ATRs ) -0.0114
Chandelier Exit (Short, 3 ATRs ) 0.1024
Upper Bollinger Band 0.0530
Lower Bollinger Band 0.0138
Percent B (%b) 0.44
BandWidth 117.3653
MACD Line -0.0111
MACD Signal Line -0.0124
MACD Histogram 0.0013
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0534
Resistance 3 (R3) 0.0555 0.0502 0.0496
Resistance 2 (R2) 0.0502 0.0445 0.0491 0.0484
Resistance 1 (R1) 0.0406 0.0410 0.0454 0.0385 0.0471
Pivot Point 0.0353 0.0353 0.0377 0.0342 0.0353
Support 1 (S1) 0.0257 0.0296 0.0305 0.0236 0.0149
Support 2 (S2) 0.0204 0.0261 0.0193 0.0136
Support 3 (S3) 0.0108 0.0204 0.0124
Support 4 (S4) 0.0087